Lactobacillus Farciminis and Hyperalgesia

Effect of a Dialy Consumption of a Probiotic (Lactobacillus Farciminis) on Hyperalgesia in Response to Thermal Stimulation

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00852865

Enrollment

Registered

2009-02-27

Start date

2009-02-28

Completion date

2009-04-30

Last updated

2009-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Pain

Keywords

Inflammation, Pain

Brief summary

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Interventions

DRUGLactobacillus farciminis

1 capsule per day. Each capsule containing 4\*109 CFU

DRUGPlacebo

1 capsule per day

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy volunteers

Exclusion criteria

* consumption of yogurts

Design outcomes

Primary

Measure	Time frame
Measurement of the mchanical pain threshold in primary and secondary areas by using a punctate stimulus.	—

Secondary

Measure	Time frame
Measurement of cutaneous temperature of hyperalgesia areas	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026